Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hajduk, P. J.
Right arrow Articles by Fesik, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hajduk, P. J.
Right arrow Articles by Fesik, S. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Strategy for High-Throughput Assay Development Using Leads Derived from Nuclear Magnetic Resonance-Based Screening

Philip J. Hajduk

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Stephen F. Betz

GeneFormatics, Inc., San Diego, CA

Jamey Mack

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Xiaoan Ruan

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Danli L. Towne

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Claude G. Lerner

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Bruce A. Beutel

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

Stephen W. Fesik

Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL

A strategy is described for the development of high-throughput screening assays against targets of unknown function that involves the use of nuclear magnetic resonance (NMR) spectroscopy. Using this approach, molecules that bind to the protein target are identified from an NMR-based screen of a library of substrates, cofactors, and other compounds that are known to bind to many proteins and enzymes. Once a ligand has been discovered, a fluorescent or radiolabeled analog of the ligand is synthesized that can be used in a high-throughput screen. The approach is illustrated in the development of a high-throughput screening assay against HI-0033, a conserved protein from Haemophilus influenzae whose function is currently unknown. Adenosine was found to bind to HI-0033 by NMR, and fluorescent analogs were rapidly identified that bound to HI-0033 in the submicromolar range. Using these fluorescent compounds, a fluorescence polarization assay was developed that is suitable for high-throughput screening and obtaining detailed structure-activity relationships for lead optimization.

Journal of Biomolecular Screening, Vol. 7, No. 5, 429-432 (2002)
DOI: 10.1177/108705702237674
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?